A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Bioavailability of Risankizumab Following Subcutaneous Dosing in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Bioavailability of Risankizumab in Pre-filled Syringe or Auto-injector in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
High Dose Risankizumab for Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Effect of Different Warm-Up Times of Risankizumab Autoinjector (AI) on the Injection Pain Experiences in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Intravenously (IV) Infused or Subcutaneously (SC) Injected Risankizumab in Healthy Adult Participants in China
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of Fluctuating Parkinson's Disease With Sensor-based Home Monitoring
- Status
- COMPLETED
- Phase
- N/A
A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE2
Venetoclax in Patients With MDS or AML in Relapse After AHSCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine
- Status
- COMPLETED
- Phase
- PHASE3